The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Characterization and identification of specific EGFR mutations in circulating tumor cells (CTCs) isolated from non-small cell lung cancer patients using antibody independent method, ApoStream.
Hai T. Tran
No relevant relationships to disclose
Vladislava O. Melnikova
Employment or Leadership Position - ApoCell
Anne S. Tsao
No relevant relationships to disclose
Frank V. Fossella
No relevant relationships to disclose
Faye M. Johnson
No relevant relationships to disclose
Vassiliki Papadimitrakopoulou
No relevant relationships to disclose
Miguel Garza
Employment or Leadership Position - ApoCell
Chris Neal
Employment or Leadership Position - ApoCell
Dave Hasegawa
Employment or Leadership Position - ApoCell
Amy Kruempel
Employment or Leadership Position - Transgenomic
Grant Wu
Employment or Leadership Position - Transgenomic
Stock Ownership - Transgenomic
Katherine Richardson
Employment or Leadership Position - Transgenomic
Stock Ownership - Transgenomic
Marcia E. Lewis
Employment or Leadership Position - Transgenomic
Stock Ownership - Transgenomic
Benjamin Jr Legendre
Employment or Leadership Position - Transgenomic
Stock Ownership - Transgenomic
Kenna Lynn Anderes
Employment or Leadership Position - ApoCell
Darren W. Davis
Employment or Leadership Position - ApoCell
John Heymach
No relevant relationships to disclose